The 2-Minute Rule for ABBV-744 in the treatment of drug-resistant cancers
In Segment A, contributors will receive different doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing regimen. Extra contributors are going to be enrolled in the discovered monotherapy dosign routine. In Segment B, members will obtain oral ruxolitinib and ABBV-744 will be given as "insert-on" therapy. In Segment C, contribu